Best Practices for Multiplex Molecular Infectious Disease Tests

Nanosphere and Xtalks will host a complimentary, P.A.C.E. accredited webinar on the best practices for justification, validation, and implementation of the Verigene Respiratory Pathogens Flex Test, Verigene Gram-Positive and Gram-Negative Blood Culture Tests, and Verigene Enteric Pathogens Test on February 24.
According to the company’s press release:

Clinical laboratories are tasked with finding cost-effective diagnostics that can produce accurate, precise, and reproducible results with a rapid turnaround time. Multiplex molecular diagnostic tests have emerged over the past decade as a viable alternative to culture-based methods for the detection of a number of different infectious diseases because these tests can deliver accurate results in a more clinically meaningful turnaround time. The adoption of multiplex infection disease tests has increased significantly as more and more publications have pointed to their ability to improve clinical and economic outcomes. This increased adoption has led to an increase in the number of diagnostic test manufacturers, which, over time, has led to a decrease in the cost and complexity associated with performing this type of testing.

Click here to view the full press release.